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Changes in cell culture conditions influence the metabolism of cells, which consequently affects the quality of the products that they produce,
such as viral vectors, recombinant proteins, or vaccines. Currently there is no effective technique available to monitor global quality of cells in cell
culture. Here we describe a new method using gene expression profiling by microarray to predict the quality of cell substrates. Human embryonic
kidney 293 cells are a commonly used cell substrate in the production of biological products. We demonstrate that the yield of adenoviral vectors
was lower in over-confluent 293 cells, compared to 40 or 90% confluent cells. Total RNA derived from these cells of different confluence states
was reverse transcribed, labeled, and used to hybridize 10K cDNA arrays to determine biomarkers for confluence states. Phenotype scatter-plot
analysis and cluster analysis were used for class discovery. Based on this approach, we identified genes that were either up-regulated or down-
modulated in response to different cell confluence states. By multivariate predictive models we identified a set of 37 genes that were either down-
regulated or up-regulated compared to 90% confluent cells as a predictor of cell confluence and quality of 293 cell cultures. The predictive
accuracy of these models was assessed by the leave-one-out cross-validation method. The expression of selected gene predictors was validated by
quantitative PCR analysis. Our results demonstrate that gene expression profiling can assess the quality of cell substrates prior to large-scale
production of a biological product.
Published by Elsevier Inc.Keywords: 293 cells; cell confluence; DNA microarray; gene expression profile; class prediction, Real-time PCRThe quality of cell substrates used to manufacture cellular
products, gene therapy products, and vaccines is of paramount
importance prior to the large-scale manufacture of the biological
products. These cells can be grown in roller bottles, tissue
culture flasks, or bioreactors for the manufacturing of large
amounts of starting material. One can assess the quality of these
cells by visual examination when cells are grown in tissue
culture flasks or in roller bottles. The color of the medium can
signal cell growth, confluence, utilization of nutrients, and need
for split of cultures to avoid cell death, senescence, and
metabolic modulation of cells. However, when cells are grown⁎ Corresponding author. Fax: +1 (301) 827 0449.
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doi:10.1016/j.ygeno.2005.11.017in a bioreactor, it is difficult to perform visual examination and
appreciate the extent of confluence of cell culture. In addition,
some cell lines, e.g., human embryonic kidney (HEK) 293 cells,
most commonly used in the production of adenoviral gene
therapy vectors and vaccines, when grown to over confluence,
exhibit a transformed phenotype. These metabolic and pheno-
typic changes in cells may pose safety risks, or produce inferior
quality, or lower yield of products, e.g., adenoviral vectors.
Furthermore, when 293 cells are infected with a replication-
defective adenoviral vector to produce adenoviral vector, viral
infection may introduce unwanted impurities in the final
product. There is no easy method of characterization of these
cell substrates. Therefore, novel approaches are needed that can
evaluate the overall condition of the starting material and help
identify biomarkers of quality that can be rapidly assessed.
Fig. 1. Effect of confluence on adenoviral yield. 293 cells at three different cell
densities were infected with an adenoviral vector. Two days later, virus was
harvested and the infectious yield (GFP units) per cell was calculated. Three
replicate infections were performed for each density. The means ± SD are
shown.
Fig. 2. Scatter-plot analysis of phenotype average. Six arrays from each cell
confluency state (90% and over confluent) were included in this analysis.
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large-scale gene expression profile of cells and tissue [1,2].
Identification and characterization of signature genes associated
with cell confluency and/or metabolic status may help identify
biomarkers to assess quality of these cells accurately. Recent
studies have demonstrated that the gene expression profile of
cells is altered in response to variations in cell culture conditions
[3–5]. Thus a gene expression profile of cells from various
confluence states may reflect the status of cells at that growth
stage. Correlating the gene expression profile with the cell
confluence state may not only shed light on cellular health, but
also provide an opportunity to develop a novel method for
quality control of biological products.
In this study, by DNA microarray analysis of 293 cells in
various confluence states, we describe a new method to (a)
identify biomarkers by using a gene expression profile and (b)
predict the confluence status by using these markers.
Results
Effect of confluence on adenoviral vector yield
To evaluate the effect of cell confluence on adenoviral
vector production, 293 cells were grown to approximately
40% confluence, 90% confluence, or over confluence. The
cell yield at 40% confluence was 3.4 × 104 cells/cm2 and was
7.5 × 104 cells/cm2 at 90% confluence and 4.7 × 105 cells/
cm2 in the over-confluent group, and all cells were viable as
determined by trypan blue dye exclusion assay. These three
confluences were selected to mimic logarithmic growth as
well as a stressed condition (over confluence) as can occur
when cells are grown in bioreactors. Cells were then infected
at a constant multiplicity of infection with adenoviral vector
AdGFP. Two days later, the adenoviral vector was harvested
and titered, and the viral yield per cell was calculated. The
adenoviral vector yield was highest when cells were infected
at 40% confluence. The titer decreased by ∼40% when cellswere transfected at 90% confluence and further dropped
(N80%) when over-confluent cells were used (Fig. 1). It is
possible that 90% cells became “too confluent” in the 2-day
culture, when cells were harvested and viral vectors were
collected. This over confluence may be responsible for the
difference in viral titers observed at 40% vs 90% confluence
states. These results indicate that adenoviral vector yield is
inversely related to the cell confluence state.
Effect of cell confluence on gene expression profile of 293 cells
The 293 cells were grown to different confluence states as
described above and total RNA was extracted. Total RNA
from 90% confluent and over-confluent cells was reverse
transcribed to cDNA and labeled with Cy5 dye. RNA from
40% confluent cells was reverse transcribed and labeled with
Cy3 dye. Labeled cDNA from 40% confluence cells served as
a reference control for 90% and over-confluent cells. The
Cy5-labeled cDNA from either over-confluent or 90%
confluent cells was mixed with the Cy3-labeled reference,
and 6 cDNA arrays for each over-confluent and 90%
confluent group were hybridized. The data obtained from
these 12 arrays were analyzed.
Scatter plot of phenotype average
Based on fold expression, genes that were differentially
expressed between over-confluent and 90% confluent cells were
subjected to a scatter-plot analysis. BRB-Array/Tools were
utilized to compare various phenotype classes. The average log
ratio of gene expression within one class was plotted on the x
axis and the average log ratio within the other class on the y
axis. Each gene was represented by a single point in the
resulting scatter plot. Outliers were defined as a plus–minus
twofold difference between the geometric mean of the
expression ratio within each of the two classes. Genes
differentially expressed between two phenotypes will fall
outside these outlier lines. As shown in Fig. 2, most genes
were classified into two major groups. Genes in region I were
up-regulated in 90% confluent cells and down-regulated in
Fig. 3. Hierarchical clustering of genes in different confluence states. The color
intensity reflects the magnitude of induction (red squares) or down-modulation
(green squares). Each row represents one gene and each column represents one
experiment. For each experiment, total RNA from 40% confluent 293 cells was
used as a common reference. Hierarchical clustering of arrays showed that
arrays representing the same confluence status were grouped together. (A) Two
major subclusters are identified. In group a genes were induced in the 90%
confluent condition and repressed in the over-confluent condition, compared
with the 40% confluent condition. In contrast, in group b genes were repressed
in the 90% confluent condition and induced in the over-confluent condition. (B)
Two groups of genes are shown: (1) a group of genes in subcluster a and (2) a
group of genes in subcluster b.
Table 1
Selected genes down-regulated in over-confluent cells
Gene
symbol
GenBank ID 90% confluent
(mean ± SD) a
Over confluent
(mean ± SD)
p value b
Cell growth and/or maintenance
CDKN1A NM_078467 4.39 ± 0.7 1.12 ± 0.4 0.0004
SEPT7 NM_001788 2.91 ± 0.9 0.79 ± 0.4 0.0051
XRCC6 NM_001469 2.25 ± 0.4 0.77 ± 0.5 0.0014
HMGA2 NM_003483 2.32 ± 0.6 0.42 ± 0.2 0.0016
ADD3 NM_016824 3.30 ± 0.9 0.99 ± 0.3 7.9 × 10–5
YARS NM_003680 2.73 ± 0.6 0.54 ± 0.2 0.0015
WARS NM_213646 2.52 ± 0.6 0.64 ± 0.3 0.0012
Cell communication
PRKAR1A NM_002734 3.71 ± 0.9 0.68 ± 0.3 0.0007
CHST10 NM_004854 3.27 ± 0.6 0.84 ± 0.5 0.0007
CSPG2 NM_004385 3.14 ± 0.7 1.37 ± 0.3 0.0085
GABBR1 NM_021905 2.44 ± 0.7 0.95 ± 0.5 0.0094
Metabolism
BHLHB2 NM_003670 2.76 ± 0.8 0.59 ± 0.2 0.0009
FKBP5 NM_004117 2.40 ± 0.8 0.48 ± 0.2 0.0009
EIF4G3 NM_003760 2.48 ± 0.3 0.49 ± 0.2 0.0082
HDLBP NM_203346 2.14 ± 0.6 0.54 ± 0.4 0.0076
HMGA2 NM_003483 2.32 ± 0.6 0.42 ± 0.2 0.0016
MAN1A1 NM_005907 2.38 ± 0.4 0.64 ± 0.3 0.0011
PTPN13 NM_080685 3.82 ± 0.8 0.91 ± 0.3 0.0064
Response to stress
XRCC6 NM_001469 2.25 ± 0.4 0.77 ± 0.5 0.0014
NFRKB NM_006165 1.85 ± 0.9 0.61 ± 0.4 0.0120
tRNA biosynthesis
YARS NM_003680 2.73 ± 0.6 0.54 ± 0.2 0.0015
WARS NM_213646 2.52 ± 0.6 0.64 ± 0.3 0.0010
a Mean ratios and SD (standard deviation) were calculated based on six
replicates in each group.
b Two-group comparison t test with unequal variance.
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regulated in 90% confluent cells and up-regulated in over-
confluent cells. These results suggested that cell confluence
status could be distinguished based on the gene expression
profile.
Hierarchical clustering analysis
For hierarchical clustering analysis, we selected genes
with expression ratios of either more than threefold greater
or threefold less than the reference (40% confluent cells) in
at least 2 arrays across the whole sample set. A total of 443
genes met these criteria and were selected for clusteranalysis. Hierarchical clustering analyses were performed on
both experiment group levels and gene expression levels. As
shown in Fig. 3A, the 12 arrays can be clustered into two
groups, a 90% confluent group and an over-confluent group.
The grouping cluster indicates that the two cell confluence
groups can be separated based on their global gene
expression profiles.
Although diverse patterns of gene expression were
observed, a careful analysis clustered these genes into two
major subclusters (a and b) (Fig. 3A). The genes in each
subcluster represented the response to cell culture condition.
Genes in subcluster a showed up-regulation of expression in
90% confluent cells compared to over-confluent cells (Fig.
3B (1), Table 1, and Supplementary Table 1S). Some of the
genes in this group were identified as cyclin-dependent
kinase inhibitor 1A (CDKN1A), cAMP-dependent protein
kinase (PRKAR1A), protein tyrosine phosphatase (PTPN13),
enolase 2 (EDO2), chondroitin sulfate proteoglycan 20
(CSPG2), cell division cycle 10 homolog (SEPT7), tyr-
osyl-tRNA synthetase (YARS), and eukaryotic translation
initiation factor 4, γ3 (EIF4G3). These genes are involved
in cell cycle regulation [13,14], cell growth, cell-to-cell
555J. Han et al. / Genomics 87 (2006) 552–559communication [15,16], transcriptional regulation [17], and
metabolism [16,18,19].
In subcluster b, a set of genes was up-regulated in over-
confluent cells compared to 90% confluent cells (Fig. 3B
(2), Table 2, and Supplementary Table 2S). These genes
were identified as NADH dehydrogenase (NDUFA6,
NDUFB3), cytochrome c oxidase (COX6C, COX7B), ATP
synthase (ATP5I, ATP5F1), ribosomal protein (RPL23A,
RPL41, RPS26), and small ribonucleoproteins (SNRPE,Table 2
Selected genes up-regulated in over-confluent cells
Gene symbol GenBank ID 90% confluent
(mean ± SD) a
Over confluent
(mean ± SD)
p value b
Cell growth and/or maintenance
ATP5G3 NM_001689 0.48 ± 0.1 1.28 ± 0.2 0.0050
MTX2 NM_006554 0.47 ± 0.2 1.78 ± 0.1 0.0011
CCT2 NM_006431 0.36 ± 0.1 1.11 ± 0.3 0.0008
NME2 NM_002512 0.42 ± 0.3 1.40 ± 0.2 0.0020
SSBP1 NM_003143 0.36 ± 0.4 1.40 ± 0.2 0.0013
Cell communication
ITGAE NM_002208 0.42 ± 0.3 1.40 ± 0.3 0.0027
RAN NM_006325 0.49 ± 0.3 1.35 ± 0.6 0.0053
SLA2 NM_175077 0.36 ± 0.3 0.98 ± 0.2 0.0019
TXN NM_003329 0.37 ± 0.3 1.45 ± 0.1 0.0019
Metabolism
CCT2 NM_006431 0.36 ± 0.1 1.11 ± 0.3 0.0008
COX5A NM_004255 0.40 ± 0.2 1.39 ± 0.1 0.0022
CYCS NM_018947 0.39 ± 0.3 1.26 ± 0.4 0.0009
HADH2 NM_004493 0.40 ± 0.2 1.19 ± 0.2 9.5 × 10–5
NDUFS6 NM_004553 0.45 ± 0.1 1.59 ± 0.2 0.0013
MRPL33 NM_004891 0.46 ± 0.2 1.67 ± 0.4 0.0010
NDUFA2 NM_002488 0.50 ± 0.2 1.54 ± 0.2 0.0020
NDUFB3 NM_002491 0.39 ± 0.2 1.35 ± 0.2 0.0008
POLR2H NM_006232 0.47 ± 0.3 1.49 ± 0.2 0.0018
POLR2L NM_021128 0.34 ± 0.2 1.47 ± 0.2 0.0013
PSMA5 NM_002790 0.39 ± 0.3 1.33 ± 0.4 0.0005
PSMB7 NM_002799 0.38 ± 0.4 1.35 ± 0.1 0.0036
UQCRQ NM_014402 0.44 ± 0.4 1.72 ± 0.2 0.0087
RPL23A NM_000984 0.61 ± 0.3 2.16 ± 0.3 0.0025
RPS26 NM_001029 0.51 ± 0.4 1.70 ± 0.4 0.0012
SNRPG NM_003096 0.38 ± 0.1 1.53 ± 0.2 0.0017
SNRPE NM_003094 0.39 ± 0.2 1.77 ± 0.3 0.0022
SSBP1 NM_003143 0.36 ± 0.4 1.40 ± 0.2 0.0013
RNF113A NM_006978 0.48 ± 0.2 2.04 ± 0.4 0.0003
Oxidative phosphorylation
ATP synthetases
ATP1B3 NM_001679 0.43 ± 0.2 1.29 ± 0.2 0.0006
ATP5F1 NM_001688 0.42 ± 0.2 1.68 ± 0.2 5.4 × 10–5
ATP5I NM_007100 0.35 ± 0.2 1.89 ± 0.2 0.0035
ATP5J NM_001003703 0.38 ± 0.1 1.47 ± 0.3 0.0037
Cytochrome c oxidases
CCT2 NM_006431 0.36 ± 0.1 1.11 ± 0.3 0.0008
COX6C NM_004374 0.57 ± 0.2 2.00 ± 0.3 0.0015
COX7B NM_001866 0.44 ± 0.1 1.81 ± 0.2 0.0007
NADH dehydrogenases
NDUFA6 NM_002490 0.50 ± 0.2 1.62 ± 0.2 0.0040
NDUFB3 NM_002491 0.39 ± 0.2 1.35 ± 0.2 0.0008
NDUFS6 NM_004553 0.45 ± 0.1 1.59 ± 0.2 0.0013
a Mean ratios and SD (standard deviation) were calculated based on six
replicates in each group.
b Two-group comparison t test with unequal variance.SNRPG). These genes are predominantly involved in cell
metabolism and maintenance [20–24].
As shown in Tables 1 and 2, several major pathways
were identified. It is readily apparent that genes belonging
to the oxidative phosphorylation pathway are distinctly up-
regulated in over-confluent cells compared to 90% confluent
cells (Table 2). Major genes in the oxidative phosphorylation
pathway included NADH dehydrogenase (NDUF A2, B3,
and S6 subcomplexes, etc.), cytochrome c oxidase (COX6C,
7B subunits, etc.), ATP synthetases (ATP5FI, ATP5I, ATP5J,
etc.), and proteasome (PSMA1, A3, A5, B7, C3 subunits,
etc.) [20–23]. In contrast, genes belonging to aminoacyl-
tRNA biosynthesis (YARS, WARS), cell maintenance and
communication (CDKN1A, SEPT7, PARKAR1A, CHST10),
and phosphatidylinositol signaling system (PTPN13) path-
ways showed a reverse expression profile (down-regulation
in the over-confluent cells compared to 90% confluent cells)
(Table 1).
Leave-one-out cross-validation and identification of biomarker
for prediction of cell quality
A total of 12 experiments were predefined into two
classes, 90% and over confluence classes. The data acquired
from all 12 experiments were subjected to filtration by
applying the following criteria: intensity at least 300 in both
Cy3 and Cy5 channels, spot size ≥30 μm. A total of 379
genes passing these criteria were selected and used in
multivariate prediction models. The significance of the gene
expression level was defined at p b 0.001 for all of the tests.
Genes with at least a fourfold difference between the two
classes were used for class prediction. Four models—
compound covariate predictor, diagonal linear discriminant
predictor, nearest centroid predictor, and support vector
machine predictor—were used. A total of 37 genes were
identified as the class predictors (Table 3). Two different cell
confluence states (90% confluent and over confluent) can be
easily distinguished by the gene expression profile of 37
genes. A set of 22 genes including CDKN1A, CHST10,
ADD3, PRKAR1A, and YARS was down-regulated when
cells became over confluent and 15 genes including ATP5I,
COX6C, NDUFA6, PDCD5, and SNRPG were up-regulated
in over-confluent cells.
The estimated accuracy of these predictive models by
cross-validation tests was 100% (Table 4). In addition, the
estimated sensitivity and specificity were also 100% (Supple-
mentary Table 3S). For accurate class prediction, the data
filtration was very critical. Since very strict criteria were set
to reduce the “noise” in this study, we were able to predict the
class 100% correctly in all four different tests. Without data
filtration, many low-intensity signals were included in the
data set, giving false predictions. When cutoff criteria were
selected at threefold, 129 genes were selected, and at twofold
231 genes were selected. As the number of genes increased
with less stringent data filtration, the percentage of correct
prediction by LOOCV dropped to between 60 and 80% (data
not shown). Based on these analyses, the expression of 37
genes was considered as a sensitive marker of cell confluence
Table 4
Class predictions for 293 cell substrate a
Experiment Confluence
class
Compound
covariate
predictor
correct?
Diagonal
linear
discriminant
predictor
correct?
Nearest
centroid
predictor
correct?
Support
vector
machines
predictor
correct?
1 90% Yes Yes Yes Yes
2 90% Yes Yes Yes Yes
3 90% Yes Yes Yes Yes
4 90% Yes Yes Yes Yes
5 90% Yes Yes Yes Yes
6 90% Yes Yes Yes Yes
7 Over Yes Yes Yes Yes
8 Over Yes Yes Yes Yes
9 Over Yes Yes Yes Yes
10 Over Yes Yes Yes Yes
11 Over Yes Yes Yes Yes
12 Over Yes Yes Yes Yes
% Correctly
classified
100 100 100 100
a Genes statistically significant at p b 0.001 with fourfold difference between
the two classes were selected for class prediction; multivariate predictors as
implemented in BRB-ArrayTool software were used for this analysis.
Fig. 4. Real-time PCR validation of selected genes. The empty columns
represent the ratio from the microarray experiment, and the solid columns
represent the ratio from the real-time PCR results.
Table 3
Predictors for quality prediction of 293 cell substrates a
Gene symbol GenBank ID 90% confluent
(geom. mean) b
Over confluent
(geom. mean)
N = 22
CDKN1A NM_078467 7.14 1.43
CD164 NM_006016 6.21 1.27
YARS NM_003680 5.99 0.64
MLLT7 NM_005938 5.95 0.93
NUP153 NM_005124 5.21 0.91
ADD3 NM_016824 5.02 0.80
PRKAR1A NM_002734 4.74 0.37
MATR3 NM_018834 4.47 0.86
CHST10 NM_004854 4.23 0.98
SCAMP1 NM_052822 4.07 0.87
PUM1 NM_014676 3.80 0.78
VIL2 NM_003379 3.75 0.92
TPM4 NM_003290 3.73 0.64
RAB6A NM_002869 3.61 0.47
ATF3 NM_001674 3.56 0.73
IGF1R NM_000875 3.40 0.54
FAT NM_005245 3.09 0.70
PCTK1 NM_006201 3.02 0.72
PSRC2 NM_144982 2.95 0.65
VCP NM_007126 2.80 0.51
SR140 XM_031553 2.59 0.61
KIF11 NM_004523 2.18 0.54
N= 15
SHFM1 NM_006304 0.47 2.23
COX6C NM_004374 0.52 2.14
NDUFA6 NM_002490 0.50 2.09
ATP5I NM_007100 0.34 1.99
COX7B NM_001866 0.43 1.93
SNRPE NM_003094 0.41 1.90
MTX2 NM_006554 0.44 1.90
UQCRQ NM_014402 0.40 1.72
TMSB10 NM_021103 0.39 1.63
SNRPG NM_003096 0.36 1.61
PDCD5 NM_004708 0.29 1.59
NDUFC1 NM_002494 0.37 1.52
TXN NM_003329 0.37 1.49
POLR2L NM_021128 0.32 1.31
NME1 NM_000269 0.31 1.25
a Class prediction at p b 0.001 significance level. Genes with at least fourfold
difference between the two classes were selected as class predictors.
b Geometric means were calculated based on six replicates in each class using
BRB-ArrayTool software.
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cell confluence states.
Validation of gene expression
To validate the expression of 37 potential biomarker genes,
quantitative real-time RT-PCR (Q-PCR) analysis was per-
formed for 12 selected genes. Q-PCR results were normalized
to both GAPDH and β-actin genes, which were shown to be
stably expressed in different cell confluence states. Fig. 4
shows results from microarray and Q-PCR analyses of
selected genes. In agreement with the microarray analysis,
gene expression of CDKN1A, YARS, and CHST10 was
down-regulated in over-confluent cells. Similarly, in agree-
ment with the microarray analysis, gene expression ofCOX6C, ATP5I, and SNRPG was up-regulated in over-
confluent cells. These results confirmed a similar trend of
gene expression data obtained from microarray analysis.
Discussion
Quality control of cell substrates used in the manufacturing
of biological products is extremely critical for the quality, safety,
and yield of the product produced. The properties of cells are
generally linked to growth conditions, e.g., pH of the medium,
pCO2, and crowding. These conditions can affect the quality of
the resultant biological products [25]. It is hypothesized that cell
confluence status may influence directly the quality and the
quantity of the biological products. There is substantial
evidence in the literature that suggests that cellular confluence
is accompanied by certain changes in cellular phenotype and
function. For example, proliferation of vascular endothelial
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cells induces cell cycle exit by inhibiting p42/p44 mitogen-
activated protein kinase activity [3]. Human hepatocarcinoma
cells undergo differentiation when grown at confluence and this
differentiation results in changes in gene expression [26].
However, there is no effective method that can globally monitor
the quality of these cells. This is an important issue, particularly
when 293 cells are used to produce adenoviral vectors as
delivery vehicles for gene therapy. In this study, we have
identified the potential molecular signature for different cell
confluence states by gene expression analysis using DNA
microarray technology and shown that the quality of these cells
can be monitored by the gene markers identified.
We demonstrate that the decrease in the yield of viral
vectors correlates with a group of genes that are modulated
in these cells. As cell confluence status influences directly
the titer of the adenoviral vector produced by 293 cells,
these genes may serve as biomarkers for cellular quality.
Several interesting observations are worth noting from the
gene expression profile. For example, genes belonging to
cell growth/maintenance and cell communication, including
CDKN1A, YARS, CHST10, and PRKAR1A, were down-
regulated when cells were over confluent (Table 1). YARS,
aminoacyl-tRNA synthetase, in addition to its essential role
in protein synthesis, has been found to be involved in
apoptosis [18] and to regulate angiogenesis [16]. Under
apoptotic conditions in cell culture, aminoacyl-tRNA syn-
thetase (YARS gene product) is secreted. This secreted
tRNA synthetase may contribute to apoptosis both by
arresting translation and by producing needed cytokines
[18]. Since 293 cells are not contact inhibited, our results
suggest that down-regulation of YARS might play a role in
reducing cell apoptosis.
Genes belonging to the oxidative phosphorylation path-
way, on the other hand, including NADH dehydrogenase,
cytochrome c oxidase (COX6C), and ATP synthetase
(ATP5I) pathways, were up-regulated in the over-confluent
condition. Because these genes are involved in the energy
generation process [20,22], up-regulation of these genes may
indicate that energy generation was increased when 293
cells became over confluent (Table 2).
To validate the molecular signature of genes to assess 293
cellular quality, class prediction by gene expression profile
was performed. Leave-one-out cross-validation tests were
performed for class prediction and for identification of gene
biomarkers for prediction. This technique has been used in
the classification of cancer subtypes [9,10,27]. In our studies,
this technique was applied to monitor cell growth status and
to identify the gene markers for classification. Four different
algorithms were applied to predict cell growth status. As we
limited analysis to genes having at least a fourfold difference
between the classes, only a small group of genes was
selected. A total of 37 genes were identified as a molecular
signature of 293 cell quality. These genes were found to be
sensitive to the cell confluence status and specifically
expressed under certain cell confluence conditions. As real-
time Q-PCR confirmed expression of a set of these genes, itis possible that these genes may serve as markers for the
quality control of 293 cells.
It is known that the confluence of cells in culture can
affect virus production and titers. However, it is not known
how to predict the effect prior to extensive downstream
processing including purification and characterization. In
addition, it is not known how to predict the effect of
adenovirus infection on the host cell substrate and the
quality of the vector they will produce ahead of time. Our
novel method provides this opportunity, saving effort and
precious resources, and also provides an opportunity to
identify reasons when production of viral or other products
fails.
The goal of this study was to identify and characterize
the signature gene markers that can be used to monitor the
cell confluence status and provide a rapid assessment of
quality of the cell substrates and cellular products. While it
is difficult to perform gene expression profiling rapidly at
this time, our results demonstrate that a small number of
genes that can predict quality can be identified. Based on
the molecular signature identified, one can perform rapid
assays such as Q-PCR to detect the expression level of the
signature gene markers. In addition, once a biomarker of 37
genes is validated, one can generate focused arrays
containing these genes and controls, which can be easily
hybridized and rapidly evaluated before isolation and
purification of the product these cells produce, saving effort
and resources.
Future studies will focus on development of rapid assays
(e.g., lab on a chip) that can process arrays in a few hours for
testing the quality of cell substrates. Our results demonstrate that
a set of 37 genes can serve as a biomarker for the quality of the
293 cell substrate to produce adenoviral vector. Since several
cell growth conditions can be clearly distinguished by the gene
expression profile, it is not surprising that class prediction tests
can give 100% correct prediction. As many cell substrates and
master cell banks are being used for the production of various
biological products, additional studies will be necessary to test
the utility of the biomarkers identified in 293 cells to compare
with other cell substrates, e.g., Vero cells.
Material and methods
Cell culture and RNA extraction
The HEK 293 cells used in this study were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine serum. The
cells were maintained at 37°C in a humidified atmosphere containing 95%
air and 5% CO2. Cell confluence stages were monitored by counting the
cell number under the microscope. Total RNA was isolated from cells in
different confluence states by Trizol reagent (Invitrogen), according to the
manufacturer’s instructions.
Adenoviral infection assay
293 cells were seeded at 2.7 × 104/cm2 in 60-mm tissue culture dishes.
Cells were grown until they reached ∼40% confluence, ∼90% confluence,
or over confluence. Cells were then infected in triplicate with the AdGFP
vector (Quantum Biotechnologies, Inc., Montreal, QC, Canada) at a
558 J. Han et al. / Genomics 87 (2006) 552–559multiplicity of infection of 10 plaque-forming units per cell. The AdGFP
vector is a replication-deficient, E1-and E3-deficient adenoviral vector that
includes a humanized green fluorescence protein (GFP) gene under
transcriptional control of the cytomegalovirus promoter [6]. After 2 days
of infection, cells were harvested, freeze–thawed three times, and
centrifuged to remove cell debris. Viral titers were assayed on 293 cells
by counting the number of green fluorescent cells.
cDNA microarray studies
The cDNA microarray slides used in this study were produced and supplied
by Advanced Technology Center, National Cancer Institute/NIH. The Incyte
human GEM2 set of cDNA clones containing 9984 features was arrayed on
poly-L-lysine-coated glass slides (detailed information can be found at the Web
site http://nciarray.nci.nih.gov/). RNA derived from 90% confluent or over-
confluent 293 cells was used as test and RNA derived from 40% confluent 293
cells as the common reference. For each set of experiments, either 90%
confluent or over-confluent 293 cells, at least six biological replicate
experiments were performed. In some cases, more than one array was
hybridized within the same experiment to confirm the quality of hybridization.
Preparation of cDNA-labeled probes was carried out using a protocol
developed by the Advanced Technology Center, NCI/NIH, with modifications
[7,8]. Briefly, 20 μg of total RNA in 19 μl dH2O was used for reverse-
transcription with 1 μl oligo(dT) primer (18-mer; 1 μg/μl). The mixture was
incubated at 70°C for 5 min and quickly chilled in ice for 5 min. A total 10-μl
reaction mixture (10× first-strand buffer, 3 μl; 20× aa-dUTP/dNTP, 2 μl; 0.1 M
DTT, 3 μl; Stratascript RT (Stratagene), 2 μl) was added to the RNA–primer mix
and incubated at 42°C for 60 min.
After incubation, synthesized cDNA was purified with a MinElute PCR
Purification Kit (Qiagen), following the manufacturer’s protocol. For dye
coupling, the cDNA pellet was resuspended into 5 μl 2× coupling buffer (0.2 M
NaHCO3, pH 9.0). A 5-μl aliquot of Cy3 or Cy5 dye (Amersham Biosciences)
was added (final concentration of coupling reaction 0.1MNaHCO3, pH 9.0; total
reaction 10 μl), and the reaction was placed in a dark box at room temperature for
60 min. After dye coupling, labeled cDNAwas purified on aMinElute column as
described above and the cDNAwas eluted in 10 μl elution buffer. After elution,
Cy3-and Cy5-labeled cDNA probes were mixed together and their volume
adjusted to 25 μl with dH2O.
A total of 25 μl purified cDNA was mixed with 1 μl (1 μg) poly(dA)
(Amersham Pharmacia Biotech), 1 μl (1 μg) COT-1 human DNA (Invitrogen), 1
μl (4 μg) yeast tRNA (Invitrogen), 1 μl 10% SDS (for 0.3% final concentration),
and 6 μl 20× SSC (for 3.5× final concentration) to a final volume of 35 μl. The
probe was denatured for 2 min at 100°C and placed onto arrays. The microarray
slides were hybridized at 65°C for 16 h and then washed successively with 2×
SSC containing 0.1% SDS for 2 min, 1× SSC for 3 min, and 0.2× SSC for 3 min.
Slides were quickly spin-dried before scanning.
Data collection and analysis
Microarray slides were scanned on a GenePix 4000B scanner (Axon
Instruments, Inc., Foster City, CA, USA) with a 10 μm resolution. Scanned
images were analyzed and the data file was generated with GenePix Pro 3.0
(Axon Instruments, Inc.) software. For data analysis, the sample set containing 12
microarray experiments, which were all biological replicates (6 from 90%
confluent and 6 from over-confluent cells), was selected, and data files were
imported into mAdb (microarray database) and analyzed by the software tools
provided by the Center for Information Technology (CIT), NIH. The advanced
filters that were applied before data analysis fulfilled the following requirements:
spot size at least 30 μm, minimum fluorescence intensity of 300 in both Cy3 and
Cy5 channels, the ratio of signal over background at least 2.0 in both channels.
These advanced filters prevented the potential effect of poor-quality spots in data
analysis. A standard global normalization approach was used for each
experiment. All of the extracted data were normalized using a 50th percentile
(median) normalization method available through the mAdb database. For
further analyses, only genes present in all of the experiments were selected,
comprising a total of 5055 genes.
For group comparison analysis, the scatter plot of phenotype averages was
performed with arrays with 90% confluence grouped in one class and arrays with
over confluence grouped as another class. A scatter plot of phenotype averagesplots the average log ratio within one group on the x axis versus the average log
ratio within the other group on the y axis. These averages are taken on a gene-by-
gene basis, and each gene is represented by a single point in the resulting scatter
plot. The scatter plot of phenotype averages was performed using BRB-
ArrayTool software provided by CIT/NIH.
For hierarchical clustering analysis, genes with a ratio either greater than
threefold or less than minus threefold in at least two arrays across the whole
sample set were selected. These genes were organized with the Pearson
correlation metric and average linkage clustering on both genes and arrays. The
cluster is color-coded using red for up-regulation and green for down-regulation.
The results are represented by a dendrogram. Hierarchical clustering analysis was
performed using the software provided by the mAdb database at CIT/NIH.
Class prediction and validation
Multivariate classification methods, as implemented in BRB-Array Tools,
version 3.2, were used to evaluate the usefulness of gene expression profiles in
predicting the class membership (i.e., samples belonging to 90% confluence or
over confluence class) of the 12 experiments. For comparative evaluations, four
multivariate methods—compound covariate predictor, diagonal linear discrim-
inant analysis, nearest centroid predictor, and support vector machine predictor
—were used in this analysis. The data were subjected to the same filtering
criteria described previously. All genes significant at p = 0.001 were used in the
models. The leave-one-out method of cross-validation was used to calculate the
misclassification rate. In this method, one sample is set aside to test the
predictive accuracy of the multivariate model. The model is then developed
using all of the remaining samples (N = 11) and its predictive accuracy is tested
on the one sample that was set aside for this purpose. The process is repeated for
all the samples available (N = 12) for the analysis. Estimates of accuracy of
prediction, sensitivity, and specificity are calculated [9–12] (for details go to
http://linus.nci.nih.gov/~brb/TechReport.htm).
Gene-specific real-time PCR
Selected potential biomarker genes were verified by real-time RT-PCR.
Briefly, the first-strand cDNAwas synthesized from 1 μg of total RNAwith an
oligo(dT) primer using Superscript II reverse transcriptase (Invitrogen,
Carlsbad, CA, USA). Total RNA and oligo(dT) primer in 32 μl dH2O were
heated at 70°C for 5 min and chilled for 3 min. The following items were added
to the tube: 10 μl of 5× buffer, 5 μl of 10 mM dNTP, and 3 μl (50 u/μl) of reverse
transcriptase. The mixture was incubated at 42°C for 90 min and then 1 μl
RNase H was added and incubated at 42°C for 10 min. The mixture was heated
at 95°C for 5 min to stop the reaction.
The resulting cDNA was amplified by using gene-specific primers (listed
in Supplementary Table 4S), and β-actin and GAPDH primers were used as
controls as reported elsewhere [7,8]. The gene-specific primers were selected
by Stratagene’s (La Jolla, CA, USA) Q-PCR primer design tool (http://
labtools.stratagene.com/). These primers were designed spanning intron–exon
boundaries to avoid amplification of genomic DNA. The specificity of
primers was verified by RT-PCR analysis. The cDNAs were labeled with the
SYBR Q-PCR master mixture (Stratagene), and reactions were carried out in
a Stratagene Mx3000P (Stratagene). The cycle conditions were PCR initial
activation step 94°C for 3 min and three-step cycling: denaturation 94°C for
30 s, annealing 50°C for 30 s, extension 72°C for 30 s. The total cycle
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